<DOC>
	<DOCNO>NCT01101256</DOCNO>
	<brief_summary>The purpose study determine residual anticoagulatory effect prophylactic therapeutic fondaparinux treatment i.e . prior surgery/intervention , pause therapy etc .</brief_summary>
	<brief_title>Determination Residual Anticoagulatory Effects Fondaparinux</brief_title>
	<detailed_description />
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Fondaparinux therapy least 3 day Age &lt; 18 year Hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>